Chapter/Section Purchase

1 Study Coverage
1.1 Therapeutic Nuclear Medicines Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Nuclear Medicines Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Nuclear Medicines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Nuclear Medicines Sales by Region
2.4.1 Global Therapeutic Nuclear Medicines Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic Nuclear Medicines by Region (2023-2028)
2.5 Global Therapeutic Nuclear Medicines Revenue by Region
2.5.1 Global Therapeutic Nuclear Medicines Revenue by Region (2017-2022)
2.5.2 Global Therapeutic Nuclear Medicines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic Nuclear Medicines Sales by Manufacturers
3.1.1 Global Top Therapeutic Nuclear Medicines Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Nuclear Medicines in 2021
3.2 Global Therapeutic Nuclear Medicines Revenue by Manufacturers
3.2.1 Global Therapeutic Nuclear Medicines Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Nuclear Medicines Revenue in 2021
3.3 Global Therapeutic Nuclear Medicines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic Nuclear Medicines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic Nuclear Medicines Sales by Type
4.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Nuclear Medicines Revenue by Type
4.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Nuclear Medicines Price by Type
4.3.1 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
4.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic Nuclear Medicines Sales by Application
5.1.1 Global Therapeutic Nuclear Medicines Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic Nuclear Medicines Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Nuclear Medicines Revenue by Application
5.2.1 Global Therapeutic Nuclear Medicines Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic Nuclear Medicines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Nuclear Medicines Price by Application
5.3.1 Global Therapeutic Nuclear Medicines Price by Application (2017-2022)
5.3.2 Global Therapeutic Nuclear Medicines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic Nuclear Medicines Market Size by Type
6.1.1 North America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
6.1.2 North America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
6.2 North America Therapeutic Nuclear Medicines Market Size by Application
6.2.1 North America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
6.2.2 North America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
6.3 North America Therapeutic Nuclear Medicines Market Size by Country
6.3.1 North America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
6.3.2 North America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic Nuclear Medicines Market Size by Type
7.1.1 Europe Therapeutic Nuclear Medicines Sales by Type (2017-2028)
7.1.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
7.2 Europe Therapeutic Nuclear Medicines Market Size by Application
7.2.1 Europe Therapeutic Nuclear Medicines Sales by Application (2017-2028)
7.2.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
7.3 Europe Therapeutic Nuclear Medicines Market Size by Country
7.3.1 Europe Therapeutic Nuclear Medicines Sales by Country (2017-2028)
7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Type
8.1.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Nuclear Medicines Market Size by Application
8.2.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Nuclear Medicines Market Size by Region
8.3.1 Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Therapeutic Nuclear Medicines Market Size by Type
9.1.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Nuclear Medicines Market Size by Application
9.2.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Nuclear Medicines Market Size by Country
9.3.1 Latin America Therapeutic Nuclear Medicines Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Type
10.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Application
10.2.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country
10.3.1 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Corporation Information
11.1.2 Novartis AG Overview
11.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis AG Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis AG Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Overview
11.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 China Isotope & Radiation Recent Developments
11.4 Q BioMed
11.4.1 Q BioMed Corporation Information
11.4.2 Q BioMed Overview
11.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Q BioMed Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Q BioMed Recent Developments
11.5 Curium Pharmaceuticals
11.5.1 Curium Pharmaceuticals Corporation Information
11.5.2 Curium Pharmaceuticals Overview
11.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Curium Pharmaceuticals Recent Developments
11.6 Jubilant DraxImage
11.6.1 Jubilant DraxImage Corporation Information
11.6.2 Jubilant DraxImage Overview
11.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jubilant DraxImage Recent Developments
11.7 Dongcheng
11.7.1 Dongcheng Corporation Information
11.7.2 Dongcheng Overview
11.7.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Dongcheng Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Dongcheng Recent Developments
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Overview
11.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lantheus Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Recent Developments
11.9 Acrotech Biopharma.
11.9.1 Acrotech Biopharma. Corporation Information
11.9.2 Acrotech Biopharma. Overview
11.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Acrotech Biopharma. Recent Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Overview
11.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Progenics Pharmaceuticals Recent Developments
11.11 International Isotopes
11.11.1 International Isotopes Corporation Information
11.11.2 International Isotopes Overview
11.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 International Isotopes Therapeutic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic Nuclear Medicines Industry Chain Analysis
12.2 Therapeutic Nuclear Medicines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Nuclear Medicines Production Mode & Process
12.4 Therapeutic Nuclear Medicines Sales and Marketing
12.4.1 Therapeutic Nuclear Medicines Sales Channels
12.4.2 Therapeutic Nuclear Medicines Distributors
12.5 Therapeutic Nuclear Medicines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic Nuclear Medicines Industry Trends
13.2 Therapeutic Nuclear Medicines Market Drivers
13.3 Therapeutic Nuclear Medicines Market Challenges
13.4 Therapeutic Nuclear Medicines Market Restraints
14 Key Findings in The Global Therapeutic Nuclear Medicines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer